Unknown

Dataset Information

0

Thiopurine S-methyltransferase pharmacogenetics: functional characterization of a novel rapidly degraded variant allozyme.


ABSTRACT: A novel human thiopurine S-methyltransferase (TPMT) variant allele, (319 T>G, 107Tyr>Asp, *27), was identified in a Thai renal transplantation recipient with reduced erythrocyte TPMT activity. The TPMT*27 variant allozyme showed a striking decrease in both immunoreactive protein level and enzyme activity after transient expression in a mammalian cell line. We set out to explore the mechanism(s) responsible for decreased expression of this novel variant of an important drug-metabolizing enzyme. We observed accelerated degradation of TPMT*27 protein in a rabbit reticulocyte lysate. TPMT*27 degradation was slowed by proteasome inhibition and involved chaperone proteins-similar to observations with regard to the degradation of the common TPMT*3A variant allozyme. TPMT*27 aggresome formation was also observed in transfected mammalian cells after proteasome inhibition. Inhibition of autophagy also decreased TPMT*27 degradation. Finally, structural analysis and molecular dynamics simulation indicated that TPMT*27 was less stable than was the wild type TPMT allozyme. In summary, TPMT*27 serves to illustrate the potential importance of protein degradation - both proteasome and autophagy-mediated degradation - for the pharmacogenetic effects of nonsynonymous SNPs.

SUBMITTER: Feng Q 

PROVIDER: S-EPMC2815203 | biostudies-literature | 2010 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Thiopurine S-methyltransferase pharmacogenetics: functional characterization of a novel rapidly degraded variant allozyme.

Feng Qiping Q   Vannaprasaht Suda S   Peng Yi Y   Angsuthum Susothorn S   Avihingsanon Yingyos Y   Yee Vivien C VC   Tassaneeyakul Wichittra W   Weinshilboum Richard M RM  

Biochemical pharmacology 20091127 7


A novel human thiopurine S-methyltransferase (TPMT) variant allele, (319 T>G, 107Tyr>Asp, *27), was identified in a Thai renal transplantation recipient with reduced erythrocyte TPMT activity. The TPMT*27 variant allozyme showed a striking decrease in both immunoreactive protein level and enzyme activity after transient expression in a mammalian cell line. We set out to explore the mechanism(s) responsible for decreased expression of this novel variant of an important drug-metabolizing enzyme. W  ...[more]

Similar Datasets

| S-EPMC1153717 | biostudies-literature
| S-EPMC2583164 | biostudies-literature
| S-EPMC3098761 | biostudies-literature
| S-EPMC4737107 | biostudies-other
| S-EPMC508655 | biostudies-other
| S-EPMC7071893 | biostudies-literature
2020-05-14 | GSE147368 | GEO
| S-EPMC3727893 | biostudies-literature
| S-EPMC5597644 | biostudies-literature
| S-EPMC3703235 | biostudies-literature